Dapsone at onset of diabetes lowers glycated hemoglobin and delays death in NOD mice

Autoimmunity

Volumn 28, Issue 3, 1998, Pages 157-161

  Peterson, Charles M ^a,d   Ahkavan, Mehras ^a   Fernandez Soto, Maria Luisa ^b   Rowell, Catherine ^a   Scott, B Keyes ^a   Peterson, Karen P ^c  

^a SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c MATECH Advanced Materials   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Autoimmune modulation; Dapsone; Diabetes prevention; NOD mouse

Indexed keywords

DAPSONE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ANIMAL EXPERIMENT; ARTICLE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; MOUSE; NONHUMAN;

EID: 0032432276     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939808996284     Document Type: Article

References (23)

1. Bowman, M.A., Leiter, E.H. and Atkinson, M.A. Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease. Immunology Today 1994; 15: 115-20.
2. Hanafusa, T., Miyagawa, J., Nakajima, H., Tomita, K., Kuwajima, M., Matsuzawa, Y. and Tarui, S. The NOD mouse. Diabetes Res. Clin. Prac. 1994; 24: S307-11.
3. Saravia-Fernandez, F., Durant, S., el Hasnaoui, A., Dardenne, M. and Homo-Delarche, F. Environmental and experimental procedures leading to variations in the incidence of diabetes in the nonobese diabetic (NOD) mouse. Autoimmunity 1996; 24: 113-21.
4. Schneider, K., Laube, H. and Linn, T. A diet enriched in protein accelerates diabetes manifestation in NOD mice. Acta Diabetologica 1996; 33: 236-40.
5. Formby, B., Miller, N., Garret, R. and Peterson, CM. Effects of low-dose cyclosporine prophylaxis in nonobese diabetic mice. J. Pharm. Exp. Ther. 1987; 241: 1106-11.
6. Sai, P. and Rivereau, A.S. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae. Diabetes Meta. 1996; 22: 341-8.
7. Pearce, R.B. and Peterson, C.M. Studies of Concanavalin A in nonobese diabetic mice. 1. Prevention of insulin-dependent diabetes. J. Pharm. Exp. Ther. 1991; 258: 710-5.
8. Mukherjee, B., Pearce, R.B., Formby, B. and Peterson, C.M. Studies of Concanavalin A in nonobese diabetic mice. II. Lymphocyte tracking and phenotype responses. J. Pharm. Exp. Ther. 1991; 258: 716-21.
9. Gazda, L.S., Baxter, A.G. and Lafferty, K.J. Regulation of autoimmune diabetes: characteristics of non-islet-antigen specific therapies. Immunol. Cell Biol. 1996; 74: 401-7.
10. Meyers, W.M. Leprosy. Dermatol. Clinics 1992; 10: 73-9.
11. Szefler, S.J. Anti-inflammatory drugs in the treatment of allergic disease. Med. Clin. North Am. 1992; 76: 953-75.
12. Coleman, M.D. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. British J. Dermatol. 1993; 129: 507-13.
13. Berlow, B.A., Liebhaber, M.I., Dyer, Z. and Spiegel, T.M. The effect of dapsone in steroid-dependent asthma. J. Allergy Clin. Immun. 1991; 87: 710-5.
14. Peterson, K.P., Van Hirtum, M. and Peterson, C.M. Dapsone decreases the cumulative incidence of diabetes in non-obese diabetic female mice. Proc. Soc. Exp. Med. Biol. 1997; 215: 262-6.
15. Dubuc, P.U., Scott, B.K. and Peterson, C.M. Sex differences in glycated hemoglobin in diabetic and non-diabetic C57B1/6 mice. Diabetes Res. Clin. Prac. 1993; 21: 95-101.
16. Booth, S.A., Moody, C.E., Dahl, M.V., Herren, M.J. and Nelson, R.D. Dapsone suppresses integrin-mediated neutrophil adherence function. J. Invest. Dermatol. 1992-98: 135-40.
17. Lang Jr., P.G. Sulfones and sulfonamides in dermatology today. J. Am. Acad. Dermatol. 1979; 1: 479-92.
18. Uetrecht, J., Zahid, N., Shear, N.H. and Biggar, W.D. Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells. J. Pharm. Exp. Ther. 1988; 245: 274-9.
19. Weiss, S.J. Tissue destruction by neutrophils. New Engl. J. Med. 1989; 320: 365-76.
20. Harrison, J.E. and Shultz, J. Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 1976; 251; 1371-4.
21. Kettle, A.J., Gedye, C.A. and Winterbourn, C.C. Superoxide is an antagonist of anti-inflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase. Biochem. Pharm. 1993; 45: 2003-10.
22. Shimada, A., Charlton, B., Taylor-Edwards, C. and Fathman, C.G. Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes 1996; 45: 1063-7.
23. Jansen, A., Rosmalen, J.G., Homo-Delarche, F., Dardenne, M. and Drexhage, H.A. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest? Journal of Autoimmunity 1996; 9: 341-8.